🔴 Veru is trading 5.4% down today amid broader biotech weakness

Veru is trading 5.4% down at $2.28, with biotech-sector weakness a possible context, not a confirmed direct cause.

• No clear Veru-specific announcement explaining the October 13 decline surfaced in the news search.
• MarketWatch’s 2:15 p.m. quote showed the XBI down 2.70%. Coverage of Veru’s earlier clinical-trial reaction dated October 10–11 does not establish a fresh October 13 catalyst.